Original HTML
IRVINE, Calif., Sept. 9, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announces the launch of Morpheus8 Cool, the next evolution of its renowned Morpheus8 technology. Available exclusively on the new expandable Morpheus8MAX platform, Morpheus8 Cool advances radiofrequency (RF) microneedling with enhanced comfort, precision, control, and safety.
Recognized as the world's #1 RF microneedling procedure, Morpheus8 is establishing a new industry standard with Morpheus8 Cool. The new handpiece and large-surface cooling tip feature game-changing Cool Comfort Technology, intelligently managing the thermal profile to elevate the treatment experience. Morpheus8 Cool also features a new interactive user interface for enhanced control and safety. Practitioners can select Guided Mode, with preset, clinically effective parameters that support consistent, repeatable outcomes, or Manual Mode for fully customizable settings.
"Developed in response to feedback from our providers, Guided Mode within the Morpheus8MAX platform offers greater versatility across their practices," said Dr. Michael Kreindel, InMode Chief Technology Officer and co-founder. "Its intuitive design gives practitioners greater flexibility to tailor treatments to each patient's skin concerns and anatomy while delivering the remarkable results patients and providers have come to expect from Morpheus8."
"Morpheus8 Cool addresses an important challenge in aesthetics: how to make a proven, successful technology even better," said Dr. Eran Krieger, Chief Medical Officer at InMode. "By cooling the skin's surface while treating the targeted tissue, we preserve the remodeling effect without compromising treatment. We are not changing the treatment—we are elevating the patient experience."
"The excitement surrounding Morpheus8 Cool was undeniable when we introduced it at our Insider Summit in Las Vegas," said Michael Dennison, InMode President, North America. "Providers immediately recognized the value of greater comfort, precision, and control, and the enthusiastic response reinforced the strong demand for this next evolution of Morpheus8 technology."
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.
Press Contact:
Behrman Cesa Communications
[email protected]
Investor Contact:
MS-IR LLC
Miri Segal – Scharia
[email protected]
SOURCE InMode Ltd.
Share this article
Original Summary
<p>IRVINE, Calif., Sept. 9, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announces the launch of Morpheus8 Cool, the next evolution of its renowned Morpheus8 technology. Available exclusively on the new expandable Morpheus8MAX...</p>
Generated Article_json
{"target_audience": "b2b", "is_medical": true, "ai_generated_title": "InMode Launches Morpheus8 Cool on New Expandable Platform", "body_html": "<p><strong>Irvine, Calif. -- [CURRENT_DATE] --</strong> InMode Ltd. (Nasdaq: INMD) has launched Morpheus8 Cool, a new radiofrequency microneedling handpiece available exclusively on its newly introduced expandable Morpheus8MAX platform.</p><h5>Morpheus8 Cool adds a large-surface cooling tip to the world's top-selling RF microneedling procedure</h5><p>The device integrates what InMode calls Cool Comfort Technology, which manages the thermal profile during treatment to improve patient comfort without altering the underlying tissue remodeling effect. Dr. Eran Krieger, InMode's Chief Medical Officer, said the goal was to preserve treatment efficacy while elevating the patient experience, rather than changing the treatment itself.</p><h5>New interface offers practitioners a choice between preset and fully customizable treatment modes</h5><p>Morpheus8Cool's redesigned interactive interface includes a Guided Mode with preset, clinically effective parameters intended to support consistent, repeatable outcomes across providers. A separate Manual Mode allows practitioners to fully customize settings for individual patient anatomy and skin concerns. InMode Chief Technology Officer and co-founder Dr. Michael Kreindel said the Guided Mode was developed directly in response to provider feedback and is designed to give practices greater flexibility.</p><h5>InMode previewed the device to providers at its Insider Summit in Las Vegas</h5><p>Michael Dennison, InMode's President for North America, said provider response at the Las Vegas event confirmed demand for greater comfort, precision, and control in RF microneedling procedures. The company positioned Morpheus8 Cool as the next iteration of its Morpheus8 platform, which it describes as the world's number one RF microneedling procedure.</p>", "meta_description": "InMode launches Morpheus8 Cool on its new Morpheus8MAX platform, adding cooling technology and dual treatment modes to its top RF microneedling device.", "seo_keywords": "InMode, Morpheus8 Cool, Morpheus8MAX, RF microneedling, aesthetic devices, medical technology, INMD", "companies": ["InMode Ltd."], "industries": ["Healthcare & Biotech"], "markets_regions": ["United States", "North America"], "news_type": ["product_launch"], "products": ["Morpheus8 Cool"], "themes": ["product_innovation", "medical_technology"], "events": ["Insider Summit"], "cta_text": "Learn more about InMode's aesthetic device technologies.", "learn_more": "https://www.inmodemd.com", "fact_check": {"accuracy_score": 100, "legal_risk": "low", "corrections_made": [], "recommendation": "publish"}}
